Les glycoprotéines d'enveloppe du rétrovirus HTLV-I

Virologie

Volumn 1, Issue 6, 1997, Pages 463-469

  Rosenberg, A R ^a   Delamarre, L ^a   Pique, C ^a   Dokhelar M C ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000329210     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion : seroconversion in recipients. Vox Sang 1984 ; 46 : 245-53.
2. Yamamoto N, Okada M, Koyanagi Y, Kannagi M, Hinuma Y. Transformation of human leukocytes by co-cultivation with an adult T cell leukemia virus producer cell line. Science 1982 ; 217 : 737-9.
3. De Thé G, Bomford R. An HTLV-I vaccine : why, how, for whom ? AIDS Res Hum Retroviruses 1993 ; 9 : 381-6.
4. Mahieux R, Ibrahim F, Mauclère P, et al. Molecular epidemiology of 58 new african human T-cell leukemia virus type 1 (HTLV-1) strains : identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies. J Virol 1997 ; 71 : 1317-33.
5. Weiss RA. Cellular receptors and viral glycoproteins involved in retrovirus entry. In : The Retroviridœ, vol. 2, edited by Levy, J.A. New York : Plenum Press, 1993 : 1-108.
6. Pique C, Pham D, Tursz T, Dokhélar MC. Human T-cell leukemia virus type I envelope protein maturation process : requirements for syncytium formation. J Virol 1992 ; 66 : 906-13.
7. Gallaher WR, Ball JM, Garry RF, Martin-Amedee AM, Montelaro RC. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 1995 ; 11 : 191-202.
8. Delamarre L, Rosenberg AR, Pique C, Pham D, Dokhélar MC. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J Virol 1997 ; 71 : 259-66.
9. Gallaher WR, Ball JM, Carry RF, Griffin MC, Montelaro RC. A general model for the transmembrane proteins of HIV and others retroviruses. AIDS Res Hum Retroviruses 1989 ; 5 : 431-40
10. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 Å resolution. Nature Struct Biol 1996 ; 3 : 465-9.
11. Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997 ; 89 : 263-73.
12. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. Atomic structure of the ectodomain from HIV-1 gp41 Nature 1997 ; 387 : 426-30.
13. Paine E, Gu R, Ratner L. Structure and expression of the human T-cell leukemia virus type 1 envelope protein. Virology 1994 ; 199 : 331-8.
14. Delamarre L, Pique C, Pham D, Tursz T, Dokhélar MC. Identification of functional regions in the human T-cell leukemia virus type 1 SU glycoprotein. J Virol 1994 ; 68 : 3544-9.
15. Rosenberg AR, Delamarre L, Pique C, Pham D, Dokhélar MC. The ectodomain of the human T-cell leukemia virus type I TM glycoprotein is involved in postfusion events. J Virol 1997 ; 71 : 7180-6.
16. Pique C, Tursz T, Dokhélar MC. Mutations introduced along the HTLV-1 envelope gene result in a non-functional protein : a basis for envelope conservation ? EMBO J 1990 ; 9 : 4243-8.
17. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin Virol 1994 ; 5 : 71-83.
18. Lodge R, Delamarre L, Lalonde JP, et al. Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein. J Virol 1997 ; 71 : 5696-702.
19. Fukudome K, Furuse M, Imai T, et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytia formation altered glycosylation of C33 antigen in HTLV-1-positive T cells. J Virol 1992 ; 66 : 1394-401.
20. Agadjanyan MG, Ugen KE, Wang B, Williams WV, Weiner DB. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection. J Virol 1994 ; 68 . 485-93.
21. Gavalchin J, Fan N, Lane MJ, Papsidero L, Poiesz BJ. Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody. Mab 34-23. Virology 1993 ; 194 : 1-9.
22. Pique C, Saal F, Périès J, Pham D, Tursz T, Dokhélar MC. Functional comparison between HTLV-I envelopes originating from TSP/HAM or ATL cell lines. J Acquir Immune Defic Syndr 1994 ; 7 : 319-24.
23. Sommerfelt MA, Williams BP, Clapham PR, Solomon E, Goodfellow PN, Weiss RA. Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science 1988 ; 242 : 1557-9.
24. Ijichi S, Ramundo MB, Takahashi H, Hall WW. In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med 1992 ; 176 : 293-6.
25. Palker TJ, Riggs ER, Spragion DE, et al. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J Virol 1992 ; 66 : 5879-89.
26. Desgranges C, Souche S, Vernant JC, Smadja D, Vahlne A, Horal P. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. AIDS Res Hum Retroviruses 1994 ; 10 : 163-73.
27. Baba E, Nakamura M, Tanaka Y, et al. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. J Immunol 1993 ; 151 : 1013-24.
28. Tanaka Y, Zeng L, Shiraki H, Shida H, Tozawa H. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol 1991 ; 147 : 354-60.
29. Sagara Y, Inoue Y, Shiraki H, Jinno A, Hoshino H, Maeda Y. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides J Virol 1996 ; 70 : 1564-9.
30. Nicot C, Astier-Gin T, Edouard E, et al. Establishment of HTLV-I-infected cell lines from French. Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res 1993 ; 30 : 317-34.
31. Kimata JT, Wong FH, Wang JJ, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones Virology 1994 ; 204 : 656-64.
32. Derse D, Mikovits J, Waters D, Brining S, Ruscetti F. Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems. J Acquir Immune Defic Syndr Hum Retroviral 1996 ; 12 : 1-5.
33. Tanaka Y, Tanaka R, Hoshino H. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell leukemia virus type-II (HTLV-II). Int J Cancer 1994 ; 59 : 655-60.
34. Cao J, Bergeron L, Heiseth E, Thali M, Repke H, Sodroski J. Effect of aminoacid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol 1993 ; 67 . 2747-55.
35. Sutton RE, Littman DR. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J Virol 1996 , 70 : 7322-6.
36. Denesvre C, Carrington C, Corbin A, et al. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol 1996 ; 70 : 4380-6.
37. Landau NR, Page KA, Littman DR. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol 1991 ; 65 : 162-9.
38. Benson J, Tschachler E, Gessain A, et al. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands. AIDS Res Hum Retroviruses 1994 ; 10 : 91-6.
39. Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, Yanagihara R. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I. J Infect Dis 1993 ; 168 : 1368-73.
40. Wattel E, Vartaman JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995 ; 69 : 2863-8.
41. Takahashi K, Takazaki T, Oki T, et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I Int J Cancer 1991 ; 49 : 673-7.
42. +, human T lymphotropic virus type-l-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. J Immunol 1991 ; 146 : 1155-62.
43. Pique C, Connan F, Levilain JP, Choppin J, Dokhélar MC. Among all human T-cell leukemia virus type 1 proteins. Tax, polymerase and envelope proteins are predicted as preferential targets for HLA-A2-restricted cytotoxic T-cell response. J Virol 1996 ; 70 : 4919-26.